DTU
DTU

Professor Rury Holman

Picture of Rury Holman Highly Cited Researcher

Position:Director

PA:Taryn Hastings
Diabetes Trials Unit
Tel: 01865 857240

Email:rury.holman@dtu.ox.ac.uk

ORCID ID0000-0002-1256-874X

Rury Holman trained in medicine at the University of Bristol in the United Kingdom, founded the University of Oxford Diabetes Trials Unit (DTU) in 1985, and was appointed as the first Professor of Diabetic Medicine at the University of Oxford in 1998. He runs an active Translational Research Group undertaking investigator-led early phase trials of novel therapeutic agents, new medical devices and complex interventions. He also designs and runs investigator-led global cardiovascular outcome trials and is currently joint Chair of EXSCEL and TECOS, and Chief Investigator of ACE and UKPDS. In addition, has a major interest in risk prediction and has co-produced the UKPDS Risk Engine and the UKPDS Outcomes Model, which is used by NICE to assess the potential impact of antidiabetic therapies. Professor Holman has received 16 national and international awards and has published over 350 peer-reviewed papers that have been cited more than 65,000 times.

Latest publications

Manuscript
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
PatrĂ­cia O. GuimarĂ£es et al.
Int J Cardiol. 2019;289:58-62

Manuscript
Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017
John M Dennis et al.
Diabetes Obes Metab 2019;21:1576-1584

Manuscript
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
M. Angelyn Bethel et al.
Diabetes Care 2019;42 :1075-1080

Manuscript
Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care
Matthew C. Riddle et al.
Diabetes Care 2019;42:1136-1146

Manuscript
Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163
Eberhard Standl et al.
Diabetes Care 2019;42:e95

Manuscript
Long-term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS 85)
E. Maddaloni et al.
Diabetes, Obesity and Metabolism 2019